Bitcoin’s Difficulty Spike Allows Miners to Pivot Markets
Bitcoin’s mining difficulty jumped about 15% to roughly 144T, signaling a rapid shift in miner economics. Early on-ch...
Ways To Earn Money Fast For Bills
Learn about effective ways to earn money fast for bills. Get actionable tips to help you manage your expenses swiftly.
15,159 articles
Pharmacy, Biology, Education Among AI-Proof Pay Gaps Exposed
A fresh federal study reveals stubbornly low starting salaries for graduates in critical fields. Here’s what it means...
Kraft Heinz, the Cost of Narrow Capitalism Unveiled
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...
Under-$1 Pre-IPO Investment Still Open to Retail Investors
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...
Former Trump Advisor: ‘Conservatives’ Threaten R&D Boom
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...
Apple’s Cook Made Times Spotlight Pay Gap at Apple
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...
Harvard Admits Easy Grades Are Too Easy, Cracks Down
Harvard's Faculty of Arts and Sciences approved a move to limit A grades for undergraduates, signaling a major bid to...
Okta (OKTA) 2027 Earnings: Growth Outlook and Risks
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...
Burford (BUR) 2026 Earnings: Q1 Insights & Outlook
Burford kicks off 2026 with a solid Q1 showing that sheds light on the company’s revenue mix, profitability, and liqu...
Billion Horse Race: Goldman Leads AI IPO Battle Ahead
Goldman Sachs and MORGAN STANLEY are jockeying for the lead left role in a pair of AI IPOs, a $7 billion opportunity ...
Ethereum Cheapest It's Been: What History Says on Investing
Ethereum trades at a level that many long-time holders never imagined, sparking questions about the next move. This a...
This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status